跳至主要内容
临床试验/NL-OMON49478
NL-OMON49478已完成不适用

Exploring the effects of a restraining force during gait in persons with post-stroke hemiparesis and able-bodied individuals - Effects of a restraining force during (hemiparetic) gait

niversitair Medisch Centrum Groningen0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - A first unilateral stroke (infarction or haemorrhage).
  • - At least twelve months post onset.
  • - A unilateral paresis of the leg.
  • - A Functional Ambulation Categories Score (FAC) of 3 (*is capable of walking
  • when a safer environment with supervision or verbal guidance is provided'*) to
  • 5 (*is independently capable of walking on flat and non-flat surfaces, on
  • slopes and is capable of walking the stairs*).
  • - Patient should be 18-70 years old at the time of inclusion.
  • - Written informed consent
  • Healthy controls:
  • - Participants should be 18-70 years old at the time of inclusion.
  • - Participants should match with one of the included patients on gender and
  • - Written informed consent

排除标准

  • - Severely impaired cognitive functions (Mini Mental State Exam score <25).
  • - Severe speech, language or communication disorders (it will be left to
  • clinical judgment whether the patient is able to understand instructions and to
  • provide informed consent; in case of doubt the Aachen Aphasia Test will be
  • administered).
  • - Insufficient working knowledge of the Dutch language to understand
  • instructions and provide informed consent (clinical judgment).
  • - Severe visual problems (clinical judgment).
  • - Severe neglect (clinical judgment through observation. In case of doubt, the
  • Star Cancelation Test can be administered).
  • - Co-morbidity that can affect the results of the study (e.g. pre-existent
  • problems in leg function or a progressive neurological disorder).
  • - Participation in other scientific studies.
  • - Use of botulin toxin injections in the lower extremities or oral spasmolytic
  • in a period of two months prior to the measurement.
  • - Use of an active splint that delivers energy for forward propulsion.
  • Healthy controls:
  • - Suffer from neurological, orthopedical, somatosensory, visual, vestibular or
  • other conditions that are known to affect the gait pattern.

研究者

相似试验